Entering text into the input field will update the search result below

Vertex Pharmaceuticals Incorporated (VRTX) CEO Jeff Leiden on Q4 2018 Results - Earnings Call Transcript

SA Transcripts profile picture
SA Transcripts

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Q4 2018 Earnings Conference Call February 5, 2019 4:30 PM ET

Company Participants

Michael Partridge - Senior Vice President, Investor Relations

Jeff Leiden - Chairman and Chief Executive Officer

Stuart Arbuckle - Chief Commercial Officer

Paul Silva - Interim Chief Financial Officer

Reshma Kewalramani - Chief Medical Officer

Conference Call Participants

Michael Yee - Jefferies

Geoffrey Porges - Leerink

Phil Nadeau - Cowen and Company

Alethia Young - Cantor Fitzgerald

Geoff Meacham - Barclays

Paul Matteis - Stifel

Terence Flynn - Goldman Sachs

Robyn Karnauskas - Citi

Brian Abrahams - RBC Capital Markets

Matthew Harrison - Morgan Stanley

Cory Kasimov - JPMorgan

Hartaj Singh - Oppenheimer and Company

Liisa Bayko - JMP Securities

Michael Partridge

Welcome to the Vertex Full Year and Fourth Quarter 2018 Financial Results Conference Call. This is Michael Partridge, Senior Vice President of Investor Relations for Vertex. Tonight, we will review our continued efforts to develop new medicines for all people with cystic fibrosis, recent advances in our research and development pipeline, and our 2018 financial results and 2019 guidance. Making prepared remarks on the call tonight, we have Dr. Jeff Leiden, Chairman and CEO; Stuart Arbuckle, Chief Commercial Officer and I would like to welcome to the call Paul Silva, Vertex’s Interim Chief Financial Officer. Paul has been Vertex’s Corporate Controller and Chief Accounting Officer since 2008. And he and his team have worked closely with the Investor Relations Group since that time. Following prepared remarks from Jeff, Stewart and Paul, Dr. Reshma Kewalramani, Chief Medical Officer will join us for Q&A. We recommend that you access the webcast slides on our website as you listen to this call. The conference call is being recorded and a replay will be on our website.

We will make forward-looking statements on this call

Recommended For You

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.